Universidad de Granada Digibug

Repositorio Institucional de la Universidad de Granada >
1.-Investigación >
Departamentos, Grupos de Investigación e Institutos >
Departamento de Bioquímica y Biología Molecular I >
DBBM1 - Artículos >

Please use this identifier to cite or link to this item: http://hdl.handle.net/10481/30995

Title: PARP-1 Regulates Metastatic Melanoma through Modulation of Vimentin-induced Malignant Transformation
Authors: Rodríguez, María Isabel
Peralta-Leal, Andreína
O'Valle, Francisco
Rodríguez-Vargas, José Manuel
González-Flores, Ariannys
Majuelos-Melguizo, Jara
López, Laura
Serrano, Santiago
García de Herreros, Antonio
Rodríguez-Manzaneque, Juan Carlos
Fernández, Rubén
Moral, Raimundo G. del
Almodóvar, José Mariano de
Oliver Pozo, Francisco Javier
Issue Date: 2013
Abstract: PARP inhibition can induce anti-neoplastic effects when used as monotherapy or in combination with chemo- or radiotherapy in various tumor settings; however, the basis for the anti-metastasic activities resulting from PARP inhibition remains unknown. PARP inhibitors may also act as modulators of tumor angiogenesis. Proteomic analysis of endothelial cells revealed that vimentin, an intermediary filament involved in angiogenesis and a specific hallmark of EndoMT (endothelial to mesenchymal transition) transformation, was down-regulated following loss of PARP-1 function in endothelial cells. VE-cadherin, an endothelial marker of vascular normalization, was up-regulated in HUVEC treated with PARP inhibitors or following PARP-1 silencing; vimentin over-expression was sufficient to drive to an EndoMT phenotype. In melanoma cells, PARP inhibition reduced pro-metastatic markers, including vasculogenic mimicry. We also demonstrated that vimentin expression was sufficient to induce increased mesenchymal/pro-metastasic phenotypic changes in melanoma cells, including ILK/GSK3-β-dependent E-cadherin down-regulation, Snail1 activation and increased cell motility and migration. In a murine model of metastatic melanoma, PARP inhibition counteracted the ability of melanoma cells to metastasize to the lung. These results suggest that inhibition of PARP interferes with key metastasis-promoting processes, leading to suppression of invasion and colonization of distal organs by aggressive metastatic cells.
Sponsorship: This work was supported by Ministerio de Ciencia e Innovación SAF2006-01094, SAF2009-13281-C02-01, Fundación La Caixa BM06-219-0 and Junta de Andalucía P07-CTS-0239 and CTS-6602 to FJO, Ministerio de Educación y Ciencia SAF2007-64597; CICYT: SAF2009-13281-C02-02; Junta de Andalucía, P06-CTS-01385 to JMRdA and grants CEIC (P10-CTS5865) and FEDER-ISCIII (PI10/00883) to JCR-M. AGdH has been funded by grants from “Fundación Científica de la Asociación Española Contra el Cáncer”, Ministerio de Ciencia y Tecnología SAF2010-16089, and “Fundación La Marató de TV3”. JCR-M has been funded by Grants CEIC (P1 = -CTS5865) and FEDER-ISCIII (PI10/00883).
Publisher: Public Library of Science (PLOS)
Keywords: Angiogenesis
Cytoskeletal proteins
Endothelial cells
Melanoma cells
Transcription factors
URI: http://hdl.handle.net/10481/30995
ISSN: 1553-7390
Rights : Creative Commons Attribution-NonCommercial-NoDerivs 3.0 License
Citation: Rodríguez, M.I.; et al. PARP-1 Regulates Metastatic Melanoma through Modulation of Vimentin-induced Malignant Transformation. Plos Genetics, 9(6): e1003531 (2013). [http://hdl.handle.net/10481/30995]
Appears in Collections:DBBM1 - Artículos

Files in This Item:

File Description SizeFormat
Rodriguez_PARP1.pdf1.69 MBAdobe PDFView/Open
Recommend this item

This item is licensed under a Creative Commons License
Creative Commons

Items in DSpace are protected by copyright, with all rights reserved, unless otherwise indicated.


Valid XHTML 1.0! OpenAire compliant DSpace Software Copyright © 2002-2007 MIT and Hewlett-Packard - Feedback

© Universidad de Granada